TIBCO Spotfire to Present at the Sixteenth Annual Biopharmaceutical Applied Statistics Symposium (BASS XVI)

SOMERVILLE, MA--(Marketwire - November 3, 2009) -

What:        TIBCO Spotfire Director of Life Sciences, Dr. Michael
             O'Connell, will present a session titled 'Graphics for
             Exploratory Analysis and Reporting in Clinical Trials' at
             the Biopharmaceutical Applied Statistics Symposium (BASS XVI)
             next week.

             Session Overview: Clinical trials are complex. With so many
             safety and efficacy endpoints, and information that must be
             summarized and disseminated to a variety of stakeholders,
             graphics can help promote better science and more effective
             communication. Dr. O'Connell will discuss how clinical
             graphics and interactive data review methods can be used to
             identify safety signals, assess protocol adherence and help
             with the analysis and reporting of safety and efficacy data.

             Session attendees will learn:
             -- The difference between exploratory and reporting graphics
                and how this impacts the analysis of clinical trials.
             -- The various graph types available from TIBCO Spotfire for
                use in exploratory analysis and the reporting of safety and
                efficacy data.
             -- How end users can create their own graphics and
                interactively review templates and share them for use on
                clinical trial data across a variety of functional areas.

Where:       The conference is being held on November 9-13, 2009 at the
             Mulberry Inn in Savannah, GA.

When:        Dr. O'Connell will present on Tuesday, November 10, 2009 at
             11:10 a.m. local time.

Information: For more information about the BASS XVI conference, visit:
             http://bass.georgiasouthern.edu.

Successful applications of the TIBCO Spotfire® enterprise analytics platform in the Life Sciences market are currently being discussed by leading pharmaceutical customers at various industry conferences, including most recently at the PhUSE 2009 conference in Basel, October 19-21, 2009, and the DIA 3rd Annual Clinical Forum in Nice, France, October 19-21, 2009. To learn more about where TIBCO Spotfire executives and customers will be presenting in the coming year, please visit TIBCO Spotfire's events page at http://spotfire.tibco.com/News/Default.aspx.

About TIBCO

TIBCO Software Inc. (NASDAQ: TIBX) is a leading provider of enterprise analytics software for next generation business intelligence. TIBCO Spotfire products offer a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://spotfire.tibco.com.

TIBCO, TIBCO Software, TIBCO Spotfire are trademarks or registered trademarks of TIBCO Software Inc. or its subsidiaries in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Contact Information: Media Inquiries Amy Groden-Morrison TIBCO Software Inc. 617-702-1710 amorriso@tibco.com http://spotfire.tibco.com Toni Iafrate Davies Murphy Group 781-418-2406 tiafrate@daviesmurphy.com http://daviesmurphy.com